FDA — authorised 16 December 1965
- Marketing authorisation holder: HOSPIRA
- Status: approved
🇺🇸 Tham in United States
FDA authorised Tham on 16 December 1965
Marketing authorisations
FDA — authorised 16 December 1965
- Application: NDA013025
- Marketing authorisation holder: HOSPIRA
- Local brand name: THAM
- Indication: SOLUTION — INJECTION
- Status: approved
Tham in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Ophthalmology approved in United States
Frequently asked questions
Is Tham approved in United States?
Yes. FDA authorised it on 16 December 1965; FDA authorised it on 16 December 1965.
Who is the marketing authorisation holder for Tham in United States?
HOSPIRA holds the US marketing authorisation.